OphthalmologyNews.net

Ophthalmology Xagena

A single-masked Phase I/II clinical study of the investigational drug Lucentis ( Ranibizumab ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degenera ...


Researchers at the University of Minnesota participated in a nationwide clinical trial that determined that many children ages seven through 17 with amblyopia ( lazy eye ) may benefit from treatments ...


Imaging data from a Phase 2 study of Pegaptanib ( Macugen ) in diabetic macular edema ( DME ) showed a reversal of capillary microaneurysms, retinal ischemia and neovascularization -- all important ...


A Phase III clinical trial of the drug Ranibizumab ( Lucentis ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration (AMD ). Approximately ...


Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies. " We found that the immune system's response to co ...